ADIPOQ and type 2 diabetes mellitus: The s-adiponectin increase before it normalized back to baseline level in newly diagnosed in the study by Miazgowski et al. (2012) suggest, together with a negative relationship to BMD, that a quick rise and following normalization in s-adiponectin may lower BMD in T2D.